Hypnotics are a group of drugs whose primary action is to produce unconsciousness. This contrasts to the opioids whose primary action is to reduce the sensation of pain and the tranquillisers whose primary action is to calm and to attenuate psychotic disease. Hypnotics of interest to the anaesthetist are the inhalational agents and intravenously administered drugs, including the barbiturates thiopentone and methohexitone, chlormethiazole, etomidate and propofol. Knowledge of the use of hypnotics to maintain anaesthesia is largely confined to the volatile anaesthetic agents, while knowledge of the use of the intravenous hypnotics is largely restricted to their use as intravenous induction agents and as sedatives for regional procedures. The use of intravenous hypnotics to maintain anaesthesia requires careful control of infusion rates based on pharmacokinetic predictions. Once techniques are established, favourable operating conditions can be achieved, as well as acceptably short recovery times. With such techniques, the benefits of freedom from many of the adverse aspects of inhalational anaesthesia can be realised.
they leave consciousness essentially intact at effective analgesic concentrations. Opioids have well-documented effects at the periphery, in the spinal cord and in the medulla, including depression of respiratory responses to carbon dioxide at relatively low concentrations. Only at high concentrations resulting from massive dosage do opioids impair consciousness, and even then amnesia may be incomplete. 2 The third major group of centrally acting drugs used by anaesthetists is the tranquillisers. The main action of this group of drugs is to calm and control psychotic symptoms. Again doses well in excess of those required to produce a significant primary effect are required to produce unconsciousness.
The primary action of the hypnotics is to produce depression of the brain from the cortex down. As the plasma concentration is increased, either due to administration of the agent via the lungs or by intravenous injection, some initial enhancement of reflexes is noted, which has been described in the case of barbiturates as antanalgesia. Dundee and Wyant 3 stress, however, that ant analgesia only occurs at subanaesthetic concentrations. In fact, low concentrations of thiopentone have been shown to reduce the ability of patients to appreciate painful stimuli applied to the skin. 4 At somewhat higher levels when surgical anaesthesia is well established, the control centres of the respiratory and cardiovascular systems are depressed. And only at extremely high levels is the function of all excitable tissues impaired. Effects on the brainstem and heart limit the plasma concentrations that can be safely achieved.
A further important action of all hypnotics, but particularly the barbiturates, is a reduction of the oxygen consumption of tissues, particularly the brain and heart, resulting in protection from hypoxic damage. Also of particular importance is the depressant effect of all hypnotics, including the barbiturates, the volatile anaesthetic agents, and even ketamine, on the con tractility of the heart which largely parallels depression of the brain. 5 The fact that each of the hypnotics depresses the myocardium in direct proportion to its effect on the central nervous system does not mean that each produces an equivalent doserelated drop in the arterial blood pressure. The actions of the various agents on peripheral resistance differ considerably. 5 Furthermore, the effect of a given hypnotic on an individual patient may vary depending on pre-existing disease states, hypovolaemia, the presence of drugs affecting the cardiovascular system and the presence of spinal or epidural anaesthesia.
The effect of the hypnotics on the EEG is also complex. In general, hypnotics produce increased activity at low levels and later slowing with increased amplitude, burst suppression and finally complete abolition of electrical activity as plasma concentrations are increased. Changes largely parallel the 'stages' of anaesthesia recognised in the volatile anaesthetics.
CLASSIFICATION OF HYPNOTICS

Hypnotic agents important to anaesthesia include the volatile anaesthetic agents halothane (Fluothane), enflurane (Ethrane) and
AnaeSfhesia and Intensive Care, Vol. 15, No. I, February, 1987 isoflurane (Forthane) and the intravenously administered agents thiopentone (Pentothal), methohexitone (Brietal), etomidate (Amidate), chlormethiazole (Hemineurin), Alfathesin and propofol (Diprivan).
The volatile anaesthetic agents have high lipid solubility which results in rapid onset of effect and rapid recovery. Intensity of effect closely follows the chemical gradient (partial pressure) established between the arterial plasma and the brain, with an almost immediate onset of action once an effective plasma level is established.
With a constant inspired concentration, accumulation occurs as the various tissue compartments of the body approach saturation. When delivery of the inhalational agent ceases, elimination from the plasma proceeds through the lungs, and by metabolism. It is most important to realise, however, that the elimination curve for each of the volatile anaesthetic agents is not a mirror image of the uptake curve. For example, the knee in the uptake curve (Fa/Fi) for halothane occurs at around 0.55, while the knee of the elimination curve (Fa/Fo) occurs at 0.30. 6 The elimination curve is in fact the result of a combination of elimination from the lungs, metabolism and the continued distribution of the volatile agent to muscle and fat. The extent of the distribution and subsequent metabolism of halothane, for example, is such that only half of the total dose is ever exhaled. 6 The intravenous hypnotic agents are similar in many ways to the volatile anaesthetic agents. In particular, they also have high lipid solubility which permits rapid equilibration between the arterial plasma and the brain. But in contrast to the volatile anaesthetic agents, they must be injected directly into the circulation in order to achieve an effective anaesthetic concentration and they rely entirely on redistribution and subsequent metabolism for reduction of the arterial plasma concentration.
As a group, the intravenous hypnotic agents are extremely useful in anaesthesia. Absence of organ toxicity and pollution of the atmosphere, low cost, their favourable effects on intracranial pressure and cerebral oxygen consumption and the avoidance of the lungs for their delivery can be of great benefit. Their use is in fact mandatory for certain types of laryngeal and tracheal surgery. New agents, particularly propofol, offer the potential for extremely rapid recovery with minimal hangover and may extend the routine use of intravenous hypnotics enormously. There remain, however, considerable difficulties in delivering intravenous agents to maintain a constant concentration in the arterial blood, particularly when one contrasts the simple techniques available for delivery of the inhalational agents.
Problems in the delivery of the intravenous agents are illustrated in Figure 1 where, using rapid arterial sampling, plasma concentrations of thiopentone have been determined in an elderly patient during induction of anaesthesia for elective repair of an abdominal aortic aneurysm. An initial bolus of 2 mg/kg results in a peak concentration of 46 mg/l followed by a decay with a small recirculation 'bump' in the curve. The patient was rendered unconscious by this dose, but awakened towards the end of the 'tail' of the curve. An identical second dose of 2 mg/kg resulted in almost twice the peak height and a generally larger area under the curve than the initial profile. It is clear that the second bolus entered when the circulation was flowing at a much slower rate than during the first injection, indicating a marked reduction in cardiac function. Further, the rapid fluctuations in plasma concentration during the few minutes shown indicate the inadequacy of the bolus dosing method for maintaining a constant plasma concentration. 
THIOPENTONE AS A PRIMARY ANAESTHETIC AGENT
Thiopentone is used for induction in the majority of anaesthetics. Its effects are extremely predictable and reproducable and its relatively low clearance 7 is of little consequence, as its action is terminated by redistribution. As a sole agent for anaesthesia, however, a much more critical approach is required to determine its suitability, adequacy and limitations.
Effective levels of anaesthesia
White and colleagues 8 found that the mean concentration of thiopentone in the plasma, together with 70070 nitrous oxide, necessary to perform dilatation and curettage without the patient responding but breathing spontaneously was 13.7 mg/l in five patients. Programmed infusions of thiopentone for patients breathing spontaneously with 70% nitrous oxide for orthopaedic procedures must maintain a level in the vicinity of 15 mg/l (Crankshawunpublished) . Another study of plasma concentrations associated with the abolition of response to squeezing the trapezius muscle confirms these observations. 9 The arterial plasma concentration at awakening is also relatively constant at 6 mg/1. 10 After infusions with thiopentone, amnesia is usually prolonged. For major inpatient surgery where pain and anxiety are often serious problems this leads to considerable patient satisfaction. Recovery from thiopentone is quite different from the recovery from volatile agents where memory returns early. Figure 1 shows that arterial plasma concentr:;ttions resulting from the administration of thiopentone by bolus injection fluctuate markedly. Large doses must be given over a relatively short period to keep a patient still. The elimination half-life of thiopentone is long, some 12 hours, clearance is typically 0.20 IImin in an adult patient, and the volume of distribution in the vicinity of 0.2 IIkg. 7 An infusion can be devised on the basis of the clearance, but it takes considerable time to reach a steady state, as the volume of distribution is large and must be loaded.
Maintenance of an effective level
Exponentially decaying infusions can be generated using the kinetic parameters of the drug. 10 Bolus doses and variable rate infusions can be tailored to a particular patient using calculated lean body mass (LBM) as an alternative to total body weight (TBW).ID Although dosage on the basis of LBM produces more uniformity of achieved plasma concentrations of thiopentone in an unselected patient population, plasma concentrations achieved using single-bolus elimination based pharmacokinetic predictions are generally low. ID A more effective way of deriving optimal infusion profiles is to match net loss of drug from the plasma with a programmed infusion using the concept of Plasma Drug EffluxY This approach requires a variable-speed, programmable syringe pump to optimise infusion rates for constant plasma concentration in successive groups of patients. The method has proved useful in determining appropriate infusion profiles for thiopentone and methohexitone where plasma concentrations have been achieved within Plasma 12 Cone. Figure 2 provides a comparison of infusion profiles expressed in units of clearance derived from conventional pharmacokinetic parameters 10 with profiles derived from the Efflux method. 11 Figure 3 shows arterial plasma levels of thiopentone in a young kidney recipient with a programmed thiopentone infusion based on the Efflux method. In practice a balanced anaesthetic technique, as used in this patient, with nitrous oxide, moderate supplements of an opioid and muscle paralysis at a maintained concentration of thiopentone in the vicinity of 10 mg/I is adequate. It may be necessary to adjust the concentration up or down in some patients as one might vary the maintenance concentration of a volatile anaesthetic agent.
Effects on the electroencephalogram
Effects of thiopentone on the EEG have been considered by many as a suitable method for quantitating the effect of hypnotic agents. However, the effects on the EEG at arterial plasma concentrations of 10 mg/l necessary for maintenance of anaesthesia are quite small. The IC so for thiopentone, the level which causes 50070 of maximal shift in the EEG frequency, is 15 mg/1. 12 This concentration is at the top-end of the range of practical anaesthetic concentrations of 7 to 15 mg/1. Further, the shift from no measurable effect at around 12 mg/l to maximum effect at 18 mg/l makes practical assessment of anaesthetic depth or control of anaesthesia by this method a daunting task. confidence limits for prediction is superimposed. 13 As well as a lack of sensitivity of the EEG throughout the useful anaesthetic range of thiopentone, the EEG shift in individual patients is extremely variable, even when one excludes data obtained during electrocautery. Figure 4 shows a scatter plot of plasma thiopentone levels versus 95070 spectral edge, pooled from six patients undergoing cardiac surgery. The straight line represents the regression function and the curved lines the 95 % confidence interval. 13 It is clear that prediction of the plasma thiopentone level from the EEG in the operating room is at best imprecise. In fact, it is likely that observation of the spontaneous EEG display for spindling, burst suppression and ultimately abolition of all activity at a plasma concentration of 20 to 25 mg/l will provide all the information that can be gained. It should be noted here that these observations apply to thiopentone and not other hypnotics, the tranquillisers or the opioids where useful information may be obtained from analysis of the EEG.
Cardiovascular effects
Bolus doses of thiopentone can achieve peak plasma concentrations in excess of 150 mg/1. 14 This is more than ten times the effective concentration for maintenance of anaesthesia by infusion. The effect of large bolus doses on the cardiovascular system of healthy patients is probably quite different from the perception of many anaesthetists. Craemmer-]orgensen and colleagues 15 administered bolus doses of thiopentone of 4 mg/kg to healthy women coming to hysterectomy and made detailed measurements of changes in cardiovascular function associated with administration of thiopentone, suxamethonium and then of intubation. Mean arterial blood pressure was found to increase by about 25% following the administration of the thiopentone alone, subsequent dosage of suxamethonium had little effect and intubation resulted in a further moderate rise. To explain these events, analysis of flow and pressure revealed that the peripheral resistance rose markedly, on average to 150% of control while the ejection fraction fell to about 75070 of control. This reflects a dramatic fall in the contractility which was counteracted by the increased resistance leading to an essentially constant or slightly increased blood pressure. Of course, if dosage is excessive or the patient is already vasconstricted, compensation will not be adequate and hypotension will result.
With bolus injections, the effect of thiopentone on the circulation is relatively brief and in general is not detected unless sophisticated equipment is used. Under infusion conditions, however, the hypertensive effects of thiopentone, at a maintained plasma concentration in the vicinity of 10 mg/l, are quite apparent as the cardiac depression is minimal. Pharmacological intervention with a vasodilator such as hydrallazine may be required.
Acquired tolerance
Dundee, Price and Drippsl6 reported that the larger the dose of thiopentone given to the patient the higher the concentration of thiopentone at awakening. They concluded that higher doses produced a tolerance in patients. These authors sampled venous blood from the hand, on the assumption that the hand would not absorb significant amounts of the drug and that levels would reflect those obtained from arterial blood. Their results have been questioned following observations of the EEG during repeated infusions of thiopentone, 12 while Figure 5 shows a comparison of waking concentrations presented by Dundee et al. 16 and our data recorded in arterial samples on waking from both induction doses and infusions of Anaesthesia and Intensive Care. Vol. 15, No. 1, February, 1987 thiopentone over widely varying doses and durations of administration. ID The results show that doses approaching ten times normal induction doses have little effect on the waking concentration and highlight the need for arterial sampling if eNS effects are to be assessed.
Effect of changes in protein binding
If one studies the ratio of bound to unbound thiopentone through the onset of cardiopulmonary bypass during a programmed infusion of thiopentone when aiming to maintain a steady concentration of 10 mg/I, massive dilution of the total concentration occurs. This is associated with a fall of some 50070 in the haematocrit due to the sudden dilution which results from the addition of some 1.5 litres of pump prime solution to the circulation. The free, active concentration of thiopentone remains relatively constant. This fortuitous effect has been shown to be directly related to the dilution of the plasma albumin to which the drug binds. 17,18 This is in contrast to the fall in concentration of fentanyl seen at the onset of cardiopulmonary bypass l9 and supports the argument for the use of an infusion of thiopentone in maintaining unconsciousness, particularly in view of the recently demonstrated cerebral protective effect. 20
Recovery from infusion
In general it is taught that as more and more thiopentone is administered, the peripheral stores become saturated and recovery is extremely slow because of the slow removal of the drug by metabolism, Such an argument is true if plasma concentrations are maintained well above the waking concentration of 6 mg/\. 10 If infusions are used to maintain a plasma concentration in the vicinity of an anaesthetic concentration of 10 mg/I during a balanced technique, a prompt fall of 30 to 50% of the arterial concentration occurs within 15 minutes or so and the patient wakens ( Figure  3) . Such a phenomenon is easy to explain if one considers that drug is cleared from the central compartment of about 5 litres at a rate of 0.2 IImin 7 so that the initial fall will be quite rapid.
Only after a quite moderate fall has occurred will a gradient be established between the peripheral and central compartments. Hence the initial rapid fall preceeds the long, slow decay over the next few hours as drug is eliminated from the peripheral stores.
Effects of active metabolites
One of the metabolic by-products of thiopentone is pentobarbitone. After two hours of infusion, some 20% of the dose of thiopentone is present as pentobarbitone. This is true whether the patient is receiving the thiopentone infusion during cardiopulmonary bypass or not. The elimination half-life of pentobarbitone is in the vicinity of 40 hours,21 which results in persistant drowsiness for a day or two if large doses of thiopentone have been given. Thiopentone levels fall somewhat faster with a half-life of 12 to 20 hours.2J This effect would clearly be detrimental for short stay cases and favour the choice of intravenous hypnotics such as etomidate, methohexitone or diprivan, none of which produces significant quantities of active metabolite. 
